Table 1.
Characteristics | No. of patients (%) |
---|---|
Age (years) | |
Median | 52 |
Range | 19‐73 |
Sex | |
Male | 147 (73.5) |
Female | 53 (26.5) |
T classification | |
T3 | 80 (40.0) |
T4 | 120 (60.0) |
N classification | |
N0 | 22 (11.0) |
N1 | 55 (27.5) |
N2 | 107 (53.5) |
N3 | 16 (8.0) |
Stage | |
III | 74 (37.0) |
IVA/IVB | 126 (63.0) |
Prescription dose (Gy) | |
70 | 95 (47.5) |
74 | 105 (52.5) |
Chemotherapy | |
≤4 cycles | 102 (51.0) |
>4 cycles | 98 (49.0) |
Targeted therapy | |
Yes | 34 (17.0) |
No | 210 (83.0) |